期刊文献+

鼠疟模型作为恶性疟原虫多表位疫苗保护性的探索试验 被引量:1

PRELIMINARY STUDIES ON MOUSE PLASMODIUM YOELII MODEL FOR THE EVALUATION OF A MULTI EPITOPE VACCINE CANDIDATE OF PLASMODIUM FALCIPARUM
下载PDF
导出
摘要 目的 :为寻找恶性疟原虫基因工程多表位疫苗保护性评价的模型动物 ,利用小鼠约氏疟原虫 ( Plas-modium yoelii)及小鼠伯氏疟原虫 ( Plasmodium berghei)模型对本实验室构建的恶性疟原虫 ( Plasmodiumfalciparum)多阶段、多表位基因工程候选疫苗进行了体内保护性及免疫模式探索试验。结果在约氏疟原虫模型 ,先用该疫苗基因的大肠杆菌表达蛋白免疫 ,后用含同一基因的重组痘苗病毒加强免疫组 ,与野生型痘苗病毒免疫组及空白对照组相比 ,小鼠的死亡时间延长 ( P<0 .0 1)。结果初步显示 。 To find a suitable animal model for the vaccine assessment of Plasmodium falciparum,Plasmodium yoelii and Plasmodium berghei of mouse were used to evaluate the protection for a multi epitope vaccine candidate of Plasmodium falciparum . Results showed that mice of the group firstly immunized with the protein expressed in E.coli ,then boosted with the recombinant vaccinia virus from the same epitopes survived longer than that of groups immunized with the wild vaccinia virus or the blank control ( P <0.01).This indicates that Plasmodium yoelii of mouse could be used as a protective model for the evaluation of multi epitope vaccine candidate of Plasmodium falciparum .
出处 《寄生虫与医学昆虫学报》 CAS 2001年第1期1-6,共6页 Acta Parasitologica et Medica Entomologica Sinica
基金 UNDP/WH O Special Programme for Research and Training in Tropical Disease ( TDR)的资助
关键词 恶性疟原虫 约氏疟原虫 疫苗 鼠疟模型 Plasmodium falciparum Plasmodium yoelii Vaccine
  • 相关文献

参考文献3

二级参考文献5

共引文献11

同被引文献19

  • 1Crotty S,Miller CJ,Lohman BL,et al.Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors[J]. J Virol,2001,75(16):7435-7452.
  • 2Hanke T,Samuel RV, Blanchard TJ. Effective Induction of Simian Immunodeficiency Virus-Specific Cytotoxic T Lymphocytes in Macaques by Using a Multiepitope Gene and DNA Prime-Modified Vaccinia Virus Ankara Boost Vaccination Regimen[J]. Journal of Virology,1999,73(9):7524-7532.
  • 3Caver TE, Lockey TD, Srinivas RV, et al. A novel vaccine regimen utilizing DNA, vaccinia virus and protein immunizations for HIV-1 envelope presentation[J]. Vaccine,1999,17(11-12):1567-1572.
  • 4Yoshida S, Kashiwamura SI, Hosoya Y, et al. Direct immunization of malaria DNA vaccine into the liver by gene gun protects against lethal challenge of Plasmodium berghei sporozoite[J]. Biochem Biophys Res Commun,2000,271(1):107-115.
  • 5Smooker PM,Setiady YY, Rainczuk A,et al. Expression library immunization protects mice against a challenge with virulent rodent malaria[J]. Vaccine,2000,18(23):2533-2540.
  • 6Hanke T,McMichael A. Pre-clinical development of a multi-CTL epi-tope-based DNA prime MVA boost vaccine for AIDS[J]. Immunol Lett,1999,66(1-3):177-181.
  • 7Nehete PN,Chitta S,Hossain MM, et al. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model[J]. Vaccine, 2001,20(5-6):813-825.
  • 8Livingston BD,Newman M,Crimi C,et al. Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines[J]. Vaccine,2001,19(32):4652-4660.
  • 9Velders MP,Weijzen S,Eiben GL,et al. Defined flanking spacers and enhanced proteolysis is essential for eradication of established tumors by an epitope string DNA vaccine[J]. J Immunol,2001,166(9):5366-5373.
  • 10Firat H,Tourdot S,Ureta-Vidal A,et al. Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A*0201 transgenic, H-2 class I KO mice[J]. Eur J Immunol,2001,31(10):3064-3074.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部